NetworkNewsBreaks – Imagin Medical Inc. (CSE: IM
Post# of 31
(Total Views: 178)
Posted On: 05/18/2021 4:10:31 PM
NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Eyes ‘Exceptional’ Work to Move i/Blue Imaging System(TM) into Commercial Manufacturing
Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, was featured in a recent article that discussed its timely progress toward 2022 completion of its innovative i/Blue Imaging System(TM). The patented system is designed leveraging proprietary light sensors and optics to improve the efficiency and accuracy of bladder cancer visualization and removal. According to the update, the on-track progress can be largely attributed to the company’s selection of Lighthouse Imaging as its manufacturing partner. “Lighthouse’s development program is focused on refining the i/Blue system’s design to ensure that the final device complies with all regulatory standards while maintaining optimal performance and remaining within a target cost and anticipated demand,” reads the article on the progress of Lighthouse, an FDA-registered and ISO-certified manufacturer. Imagin Medical Director of Engineering and Quality Mike Vergano indicated that Lighthouse was selected to assist in moving the i/Blue System into commercial manufacturing due to its cross-functional expertise in electronics, optics, software and mechanical design. Quoted in the article, he stated, “The Lighthouse team’s work to-date has been exceptional, and we look forward to that continuing.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, was featured in a recent article that discussed its timely progress toward 2022 completion of its innovative i/Blue Imaging System(TM). The patented system is designed leveraging proprietary light sensors and optics to improve the efficiency and accuracy of bladder cancer visualization and removal. According to the update, the on-track progress can be largely attributed to the company’s selection of Lighthouse Imaging as its manufacturing partner. “Lighthouse’s development program is focused on refining the i/Blue system’s design to ensure that the final device complies with all regulatory standards while maintaining optimal performance and remaining within a target cost and anticipated demand,” reads the article on the progress of Lighthouse, an FDA-registered and ISO-certified manufacturer. Imagin Medical Director of Engineering and Quality Mike Vergano indicated that Lighthouse was selected to assist in moving the i/Blue System into commercial manufacturing due to its cross-functional expertise in electronics, optics, software and mechanical design. Quoted in the article, he stated, “The Lighthouse team’s work to-date has been exceptional, and we look forward to that continuing.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Imagin Medical Inc. (IMEXF) Stock Research Links
Scroll down for more posts ▼